Clinical Trials on Malignant Solid Neoplasm in Switzerland

Total 2047 results

Incyte Corporation

Terminated

Efficacy and Safety of Pemigatinib in Previously Treated Locally Advanced/Metastatic or Surgically Unresectable Solid Tumor Malignancies Harboring Activating FGFR Mutations or Translocations (FIGHT-207)

Solid Tumor Malignancy

United States, France, United Kingdom, Italy, Korea, Republic of, Japan, Spain, Israel, Denmark, Germany, Switzerland
University Hospital, Basel, Switzerland

Completed

Anti-EGFR Immunoliposomes in Solid Tumors

Solid Tumors

Switzerland
University of Zurich

Unknown

Associating Liver Partition With Portal Vein Ligation for Staged Hepatectomy (ALPPS) vs. Two-Stage Hepatectomy (TSH) for Marginally Resectable Colorectal Liver Metastases (CRLM) (ALPPSforCRLM)

Liver Diseases | Liver Neoplasms | Hepatectomy | Surgery | Secondary Malignant Neoplasm of Liver | Colon Cancer Liver Metastases | Malignant Neoplasm of Large Intestine Metastatic to Liver

Switzerland
Kantonsspital Graubuenden

Unknown

Effect of Bevacizumab and VEGF on Platelet Clustering in Patients Who Are Receiving Bevacizumab for Cancer

Unspecified Childhood Solid Tumor, Protocol Specific | Unspecified Adult Solid Tumor, Protocol Specific

Switzerland
Maxivax SA

Active, not recruiting

MVX-ONCO-1 in Patients With Solid Tumor

Cancer | Solid Tumor

Switzerland
Centre Hospitalier Universitaire Vaudois

Terminated

Adoptive Transfer Of Autologous Tumor-Infiltrating Lymphocytes in Solid Tumors

Solid Tumor, Adult

Switzerland
Southern Europe New Drug Organization
Pierre Fabre Laboratories; Agennix

Unknown

Satraplatin and Vinorelbine in Advanced Solid Tumors

Advanced Solid Tumors

Switzerland
Rolf Inderbitzi
Clinical Trial Unit Ente Ospedaliero Cantonale

Unknown

Malignant Pleural Effusion: Pleur-X vs. Chemical Pleurodesis in VATS (Pleur-X)

Malignant Pleural Effusion

Switzerland
Centre Hospitalier Universitaire Vaudois

Completed

RACIN in Patients With Advanced TIL-negative Solid Tumors (RACIN)

Solid Tumor, Adult

Switzerland
Centre Hospitalier Universitaire Vaudois

Active, not recruiting

NeoTIL in Advanced Solid Tumors

Solid Tumor, Adult

Switzerland
Maxivax SA
CATO-SMS

Withdrawn

MVX-ONCO-2 in Advanced Solid Tumors

Solid Tumor, Adult

Switzerland
Swiss Group for Clinical Cancer Research

Completed

Combination Chemotherapy Before Surgery in Treating Patients With Mesothelioma of the Lung

Malignant Mesothelioma

Switzerland
TOLREMO therapeutics AG

Recruiting

A Study Evaluating the Safety, Tolerability, Pharmacokinetics, and Efficacy of TT125-802 in Subjects With Advanced Solid Tumors (TT-CSP-001)

Cancer | Adult Solid Tumor | Advanced Solid Tumor | Adult Disease

Spain, Switzerland
Southern Europe New Drug Organization
Novartis

Unknown

LBH589 Oral in Combination With Carboplatin and Paclitaxel in Advanced Solid Tumors

Advanced Solid Tumors

Switzerland
Southern Europe New Drug Organization
Celgene Corporation

Unknown

Lenalidomide and Paclitaxel in Advanced Solid Tumors

Advanced Solid Tumors

Switzerland, Italy
Southern Europe New Drug Organization
Novartis; Schering-Plough

Unknown

Dose-finding Study of CAELYXTM and RAD001 in Patients With Advanced Solid Tumors

Advanced Solid Tumors

Italy, Switzerland
AstraZeneca

Terminated

AZD2281 in Combination With Liposomal Doxorubicin in Advanced Solid Tumours

Solid Tumors

Italy, Switzerland
PharmaMar

Completed

Study of Lurbinectedin (PM01183) in Combination With Cisplatin in Patients With Solid Tumors

Advanced Solid Tumors

United Kingdom, Switzerland
University of Zurich
Swiss National Science Foundation; Swiss Accident Insurance Fund SUVA

Completed

Intracavitary Cisplatin-Fibrin Localized Chemotherapy After P/D or EPP for Malignant Pleural Mesothelioma

Malignant Pleural Mesothelioma

Switzerland
University of Zurich

Terminated

PET/MRI Perfusion and CT Perfusion in Solid Tumors (Perfusion)

CT Perfusion and MRI Perfusion in Solid Tumors

Switzerland
Swiss Group for Clinical Cancer Research

Recruiting

TLD-1, a Novel Liposomal Doxorubicin, in Patients With Advanced Solid Tumors

Advanced Solid Tumors

Switzerland
University of Zurich

Completed

Re-directed T Cells for the Treatment (FAP)-Positive Malignant Pleural Mesothelioma

Malignant Pleural Mesothelioma

Switzerland
Philogen S.p.A.

Recruiting

Safety and Early Signs of Efficacy of IL12-L19L19. (DODEKA)

Advanced Solid Tumor | Metastatic Solid Tumor

Italy, Germany, Switzerland
University Hospital, Basel, Switzerland

Not yet recruiting

Safety and Modulation of Adaptive Immunity by Iscador® Qu Viscum Album Extract in Patients With Advanced, Recurrent or Metastatic Cancers Treated With Immune Checkpoint Inhibitors (ISCA-CHECK)

Advanced Solid Tumor

Switzerland
European Organisation for Research and Treatment...
ETOP IBCSG Partners Foundation

Completed

SPECTAlung: Screening Patients With Thoracic Tumors for Efficient Clinical Trial Access (SPECTAlung)

Any Stage of Lung Cancer (Any Histotype) | Any Stage of Malignant Pleural Mesothelioma | Any Stage of Any Thymic Malignancy

Spain, Belgium, Ireland, Slovenia, France, United Kingdom, Poland, Italy, Switzerland
Swiss Group for Clinical Cancer Research

Completed

Lurbinectedin Monotherapy in Patients With Progressive Malignant Pleural Mesothelioma.

Malignant Pleural Mesothelioma, Advanced

Switzerland, Italy
Cytos Biotechnology AG

Completed

Safety and Immunogenicity of a Melan-A VLP Vaccine in Advanced Stage Melanoma Patients

Malignant Melanoma

Switzerland
Hoffmann-La Roche

Completed

A Pharmacokinetic and Metabolism Study of 14C-labeled RO5185426 on Patients With Metastatic Melanoma

Malignant Melanoma

Switzerland
Cantonal Hospital of St. Gallen
University Hospital, Geneva; University Hospital Muenster; Stanford University; University of Toronto and other collaborators

Recruiting

Microsurgical Resection of Intramedullary Spinal Cord Metastases

Spinal Cord Neoplasms | Radiotherapy; Complications | Functional Outcome | Spinal Cord Metastasis | Spinal Cord Tumor Malignant Intramedullary

Switzerland
PIQUR Therapeutics AG

Completed

A Study to Investigate Safety, Pharmacokinetics (PK) and Pharmacodynamics (PD) of PQR309

Advanced Solid Tumors

Switzerland
Centre Hospitalier Universitaire Vaudois

Recruiting

Irradiation of Melanoma in a Pulse (IMPulse)

Metastasis From Malignant Melanoma of Skin (Diagnosis)

Switzerland
Swiss Group for Clinical Cancer Research
Immunophotonics, Inc.

Recruiting

Intratumoral Injection of IP-001 Following Thermal Ablation in Patients With Advanced Solid Tumors.

Advanced Solid Tumors

Switzerland
Bristol-Myers Squibb

Terminated

A Dose Escalation and Combination Immunotherapy Study to Evaluate BMS-986226 Alone or in Combination With Nivolumab or Ipilimumab in Patients With Advanced Solid Tumors

Cancer | Neoplasm | Tumors | Malignancy

United States, Canada, Spain, Switzerland
Markus Joerger

Recruiting

Tinostamustine and Nivolumab in Advanced Melanoma (ENIgMA)

Malignant Melanoma

Switzerland
Cytos Biotechnology AG

Completed

Safety and Immunogenicity of a Melan-A VLP Vaccine in Early Stage Melanoma Patients

Malignant Melanoma

Switzerland
Thomas Zilli
University Hospital, Geneva

Recruiting

Total Marrow Irradiation With Volumetric Arc Therapy for Patients Unfit for a 12 Gy TBI

Haematological Malignancy

Switzerland
University Children's Hospital, Zurich

Completed

Magnetic Resonance (MR) Guided Focused Ultrasound in the Treatment of Brain Tumors (FUS-Tumor)

Malignant Brain Tumors

Switzerland
Merck Sharp & Dohme LLC

Completed

Study of MK-8353 + Selumetinib in Advanced/Metastatic Solid Tumors (MK-8353-014)

Solid Tumors

United States, Canada, Switzerland
Glycotope GmbH

Completed

CetuGEX™: Phase 1 Study in Cancer Patients

Solid Tumors

Germany, Italy, Switzerland
Cytos Biotechnology AG

Completed

Safety and Immunogenicity of CYT004-MelQbG10 Vaccine With and Without Adjuvant in Advanced Stage Melanoma Patients

Malignant Melanoma

Switzerland
Centre Hospitalier Universitaire Vaudois

Terminated

Photo-induction as a Means to Improve Cisplatin Delivery to Pleural Malignancies (PDT-lipo)

Pleural Effusion, Malignant

Switzerland
Novartis Pharmaceuticals

Completed

Study to Evaluate Panobinostat (DACi) Pharmacokinetics and Safety in Solid Tumors and Varying Renal Function

Advanced Solid Tumors

Switzerland, Netherlands, United States, United Kingdom
Oncology Institute of Southern Switzerland
Ente Ospedaliero Cantonale, Bellinzona; Istituto Cantonale di Patologia

Recruiting

Tumor Molecular Profiling in Early Phase Clinical Trials

Lymphoma | Advanced Solid Tumor

Switzerland
Debiopharm International SA

Recruiting

A Study to Evaluate Safety and Preliminary Anti-tumor Activity of Debio 0123 as Monotherapy in Adult Participants With Advanced Solid Tumors

Advanced Solid Tumors

Spain, United States, Switzerland
University Hospital, Basel, Switzerland
University of Basel

Completed

Bioavailability Mechanistic Study of Hot-Melt Extruded Amorphous Solid Dispersions (BEAD)

Biological Availability | Amorphous Solid Dispersions

Switzerland
Children's Oncology Group
National Cancer Institute (NCI)

Recruiting

Genetic Analysis in Identifying Late-Occurring Complications in Childhood Cancer Survivors

Childhood Malignant Neoplasm

United States, Canada, Australia, Puerto Rico, Switzerland
Novian Health Inc.

Recruiting

Confirmatory Clinical Evaluation of Novilase® Laser Therapy for Focal Destruction of Malignant Breast Tumors

Malignant Neoplasm of Breast

Switzerland, United States, Germany
Novartis Pharmaceuticals

Completed

Pharmacokinetics and Safety of Panobinostat in Patients With Advanced Solid Tumors and Various Degrees of Hepatic Function

Advanced Solid Tumors

Switzerland, Sweden, Netherlands, United States, United Kingdom
Glycotope GmbH

Completed

PankoMab-GEX™: Phase 1 Dose Escalation Study

Solid Tumors

Germany, Italy, Switzerland
University Hospital Inselspital, Berne

Active, not recruiting

CD34+ Selected ASCT for Aggressive Lymphomas (SAAL)

Malignant Non-Hodgkin Lymphomas

Switzerland

Clinical Trials on Malignant Solid Neoplasm in Switzerland

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Portugal

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations